Clinical Trial

Drug Excretion in Breast Milk

Name: Drug Excretion in Breast Milk — clinical trial record (NCT06056583)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2023-09-20; most recent amendment 2024-08-02.

Trial Details

NCT Number	NCT06056583
Lead Sponsor	University of Washington Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions	Postpartum, Lactation, Drugs in Breast Milk, Mammary Drug Transporters, BCRP, OCT1
Enrollment	50 participants
Start Date	2023-12-04
Primary Completion	2028-09-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-08-06